Research project: Prospective evaluation of the efficacy and safety of lapatinib after personalization of its dosage by pharmacotherapeutic monitoring of plasma levels
QT20130710-2
Code
QT20130710-2
Promoter
Plataforma Oncología. Hospital Quirónsalud Torrevieja.
Pathology and candidate patients
Cancer. Patients with cancer treated with lapatinib.
High resolution image. This link will open using lightbox, there may be a context switchMedical equipment
Dr. Belén Valenzuela Jiménez
Plataforma oncología. Hospital Quirónsalud Torrevieja.
Study status
Initiated.
Test product
Lapatinib
Date CEIC
10/07/2013
CEIC
Comité Ético Investigación Hospital Quirónsalud Torrevieja.
Contact
If you are interested in this clinical trial because you believe that you or a family member of yours can benefit from this new treatment. You can request a consultation with the responsible specialist in our center [Dr. Belén Valenzuela Jiménez] by sending an email to the address: belen.valenzuela@quironsalud.es